Cargando…
Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
Nanomedicines have been extensively explored for cancer treatment, and their efficacies have arguably been proven in various cancer cell-derived xenograft (CDX) mouse models. However, they generally fail to show such therapeutic advantages in patients because of the huge pathological differences bet...
Autores principales: | Wang, Hangxiang, Zhou, Liqian, Xie, Ke, Wu, Jiaping, Song, Penghong, Xie, Haiyang, Zhou, Lin, Liu, Jialin, Xu, Xiao, Shen, Youqing, Zheng, Shusen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071539/ https://www.ncbi.nlm.nih.gov/pubmed/30083272 http://dx.doi.org/10.7150/thno.26161 |
Ejemplares similares
-
Structure-Based Rational Design of Prodrugs To Enable Their Combination with Polymeric Nanoparticle Delivery Platforms for Enhanced Antitumor Efficacy**
por: Wang, Hangxiang, et al.
Publicado: (2014) -
Cancer Nanomedicines Stabilized by π-π Stacking between Heterodimeric Prodrugs Enable Exceptionally High Drug Loading Capacity and Safer Delivery of Drug Combinations
por: Wang, Hangxiang, et al.
Publicado: (2017) -
Stimuli-responsive prodrug-based cancer nanomedicine
por: Xie, Angel, et al.
Publicado: (2020) -
Nanoparticle formulation of mycophenolate mofetil achieves enhanced efficacy against hepatocellular carcinoma by targeting tumour‐associated fibroblast
por: Yang, Zhentao, et al.
Publicado: (2021) -
Engineering Prodrug Nanomedicine for Cancer Immunotherapy
por: Yang, Bin, et al.
Publicado: (2020)